FOLH1 and neoplasm: One major issue is the on-target, off-tumor effect: BiTEs target tumor-associated antigens that can also be expressed in normal tissues, potentially leading to unintended immune attacks on healthy cells—for example, PSMA-targeting BiTEs may affect normal tissues that express PSMA [72].